Toripalimab Recruiting Phase 2 Trials for Localized Mucosal Melanoma / Mucosal Melanoma Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04180995Toripalimab in Combination With Axitinib in Patients With Localized Mucosal Melanoma
NCT03178123The Study of JS001 Compared to High-Dose Interferon In Patients With Mucosal Melanoma That Has Been Removed by Surgery